Reports from Zhejiang University Advance Knowledge in Multiple Myeloma (Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study)

Prensa/medios de comunicación: !!!Research

Períododic. 24 2024

Cobertura de los medios

1

Cobertura de los medios

  • NombreReports from Zhejiang University Advance Knowledge in Multiple Myeloma (Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study)
    Nombre/canal del medio de comunicaciónImmunotherapy Daily
    País/TerritorioEstados Unidos
    Fecha24/12/24
    PersonasYang Yang
Ver todos 1
Ver menos